Species | Erysipelatoclostridium spiroforme | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lineage | Bacteria; Firmicutes; Bacilli; Erysipelotrichales; Erysipelatoclostridiaceae; Erysipelatoclostridium; Erysipelatoclostridium spiroforme | |||||||||||
CAZyme ID | MGYG000001304_00124 | |||||||||||
CAZy Family | CBM32 | |||||||||||
CAZyme Description | hypothetical protein | |||||||||||
CAZyme Property |
|
|||||||||||
Genome Property |
|
|||||||||||
Gene Location | Start: 156090; End: 162110 Strand: + |
Family | Start | End | Evalue | family coverage |
---|---|---|---|---|
GH89 | 243 | 887 | 1.7e-228 | 0.971342383107089 |
CBM32 | 38 | 157 | 7.4e-16 | 0.9274193548387096 |
Cdd ID | Domain | E-Value | qStart | qEnd | sStart | sEnd | Domain Description |
---|---|---|---|---|---|---|---|
pfam05089 | NAGLU | 6.32e-134 | 302 | 628 | 1 | 333 | Alpha-N-acetylglucosaminidase (NAGLU) tim-barrel domain. Alpha-N-acetylglucosaminidase, a lysosomal enzyme required for the stepwise degradation of heparan sulfate. Mutations on the alpha-N-acetylglucosaminidase (NAGLU) gene can lead to Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) characterized by neurological dysfunction but relatively mild somatic manifestations. The structure shows that the enzyme is composed of three domains. This central domain has a tim barrel fold. |
pfam12972 | NAGLU_C | 2.84e-89 | 636 | 895 | 1 | 250 | Alpha-N-acetylglucosaminidase (NAGLU) C-terminal domain. Alpha-N-acetylglucosaminidase, a lysosomal enzyme required for the stepwise degradation of heparan sulfate. Mutations on the alpha-N-acetylglucosaminidase (NAGLU) gene can lead to Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) characterized by neurological dysfunction but relatively mild somatic manifestations. The structure shows that the enzyme is composed of three domains. This C-terminal domain has an all alpha helical fold. |
pfam12971 | NAGLU_N | 4.99e-28 | 204 | 287 | 1 | 81 | Alpha-N-acetylglucosaminidase (NAGLU) N-terminal domain. Alpha-N-acetylglucosaminidase, a lysosomal enzyme required for the stepwise degradation of heparan sulfate. Mutations on the alpha-N-acetylglucosaminidase (NAGLU) gene can lead to Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) characterized by neurological dysfunction but relatively mild somatic manifestations. The structure shows that the enzyme is composed of three domains. This N-terminal domain has an alpha-beta fold. |
pfam00754 | F5_F8_type_C | 6.24e-10 | 35 | 157 | 1 | 127 | F5/8 type C domain. This domain is also known as the discoidin (DS) domain family. |
pfam00754 | F5_F8_type_C | 5.72e-07 | 933 | 1051 | 1 | 127 | F5/8 type C domain. This domain is also known as the discoidin (DS) domain family. |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End |
---|---|---|---|---|---|
AYE33274.1 | 0.0 | 23 | 1954 | 27 | 2131 |
QAS61445.1 | 0.0 | 23 | 1954 | 27 | 2131 |
ABG84150.1 | 0.0 | 24 | 1744 | 20 | 1920 |
AMN35090.1 | 0.0 | 24 | 1744 | 29 | 1929 |
AMN32327.1 | 0.0 | 24 | 1744 | 29 | 1929 |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
---|---|---|---|---|---|---|
2VC9_A | 0.0 | 36 | 923 | 10 | 890 | Family89 Glycoside Hydrolase from Clostridium perfringens in complex with 2-acetamido-1,2-dideoxynojirmycin [Clostridium perfringens],2VCA_A Family 89 glycoside hydrolase from Clostridium perfringens in complex with beta-N-acetyl-D-glucosamine [Clostridium perfringens],2VCB_A Family 89 Glycoside Hydrolase from Clostridium perfringens in complex with PUGNAc [Clostridium perfringens],2VCC_A Family 89 Glycoside Hydrolase from Clostridium perfringens [Clostridium perfringens] |
4A4A_A | 0.0 | 36 | 923 | 33 | 913 | CpGH89(E483Q, E601Q), from Clostridium perfringens, in complex with its substrate GlcNAc-alpha-1,4-galactose [Clostridium perfringens] |
7MFK_A | 0.0 | 36 | 923 | 18 | 898 | ChainA, Alpha-N-acetylglucosaminidase family protein [Clostridium perfringens ATCC 13124],7MFL_A Chain A, Alpha-N-acetylglucosaminidase family protein [Clostridium perfringens ATCC 13124] |
4XWH_A | 3.93e-90 | 208 | 861 | 11 | 663 | Crystalstructure of the human N-acetyl-alpha-glucosaminidase [Homo sapiens] |
4A6O_A | 8.93e-28 | 1062 | 1193 | 25 | 160 | CpGH89CBM32-4,produced by Clostridium perfringens, in complex with glcNAc-alpha-1,4-galactose [Clostridium perfringens],4A6O_B CpGH89CBM32-4, produced by Clostridium perfringens, in complex with glcNAc-alpha-1,4-galactose [Clostridium perfringens] |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
---|---|---|---|---|---|---|
Q9FNA3 | 5.03e-99 | 224 | 899 | 64 | 794 | Alpha-N-acetylglucosaminidase OS=Arabidopsis thaliana OX=3702 GN=NAGLU PE=2 SV=1 |
P54802 | 2.01e-89 | 208 | 861 | 34 | 686 | Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2 |
E8MGH9 | 1.86e-12 | 1753 | 2006 | 1666 | 1933 | Beta-L-arabinobiosidase OS=Bifidobacterium longum subsp. longum (strain ATCC 15707 / DSM 20219 / JCM 1217 / NCTC 11818 / E194b) OX=565042 GN=hypBA2 PE=1 SV=1 |
P26831 | 5.80e-09 | 1703 | 1952 | 1321 | 1566 | Hyaluronoglucosaminidase OS=Clostridium perfringens (strain 13 / Type A) OX=195102 GN=nagH PE=1 SV=2 |
Other | SP_Sec_SPI | LIPO_Sec_SPII | TAT_Tat_SPI | TATLIP_Sec_SPII | PILIN_Sec_SPIII |
---|---|---|---|---|---|
0.000291 | 0.998939 | 0.000266 | 0.000173 | 0.000161 | 0.000139 |
Copyright 2022 © YIN LAB, UNL. All rights reserved. Designed by Jinfang Zheng and Boyang Hu. Maintained by Yanbin Yin.